KAO
2.5
237.8%
CTD
2.25
-86%
VR8
0.027
92.9%
STG
0.145
-37%
AM7
0.065
62.5%
CHM
0.008
-27.3%
PR2
0.068
58.1%
REG
4.54
-27%
IRD
0.011
57.1%
GTN
0.195
-26.4%
WSI
0.085
51.8%
ARO
0.003
-25%
GGM
0.25
47.1%
BLU
0.003
-25%
WEC
0.305
41.9%
AIH
0.41
-21.2%
SOP
0.075
41.5%
SEQ
0.071
-20.2%
AS2
0.007
40%
BNL
0.004
-20%
EXR
0.065
35.4%
CCE
0.2
-20%
TET
0.375
33.9%
EVR
0.004
-20%
SER
0.2
33.3%
SIS
0.004
-20%
RAP
0.03
30.4%
IRI
0.29
-19.4%
NAG
0.013
30%
MX1
0.022
-18.5%
C29
0.022
29.4%
BST
0.315
-18.2%
XRA
0.29
28.9%
TTT
0.14
-17.6%
BAP
0.875
28.7%
TRJ
0.17
-17.1%
AHL
1.58
27.9%
ACS
0.29
-17.1%
FTI
0.8
27%
GBL
0.015
-16.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Curvebeam AI (ASX:CVB): Developing enhancements to the HiRise™ platform

Curvebeam AI (ASX:CVB) is building artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions. The current focus of management is to support its U.S. growth strategy and further its Stryker partnership | Investor presentation: https://wcsecure.weblink.com.au/pdf/CVB/02800840.pdf